Jonathan Barratt

Jonathan Barratt

Company: University of Leicester

Job title: Professor of Renal Medicine

Seminars:

Panel Discussion | Enhancing Global Inclusion of Underserved Communities in CKD Trials for Greater Representation in Clinical Samples 9:00 am

Opening up trials to more countries to address underserved populations Exploring case studies of conducting CKD trials in different countries Highlighting the benefits of expanding the reach into more countriesRead more

day: Conference Day 2

Panel Discussion | Bringing Drugs Evaluated in Trial Cohorts Selected Based on Proteinuria Enrichment into Practical Application in Real-World Scenarios 11:00 am

Recognizing that the enrichment criteria employed in a trial do not necessarily limit a drug’s suitability exclusively to that specific population in real-world scenarios Translating the evidence generated in trials into suitable recommendations for treating patients with varying UACRs Discussing how clinical practice guidelines anticipate keeping pace with the rapidly evolving landscape of new CKD…Read more

day: Day 2 Track 3 AM

Chair’s Opening Remarks 9:25 am

Read more

day: Pre-Conference Seminar Day

Unravelling the Epidemiological Factors Associated with IgA Nephropathy to Shoot for Targets of Greatest Unmet Need 10:00 am

Exploring geographic and environmental variabilities that result in more aggressive phenotypes Understanding how the epidemiology of IgA feeds into target identification and validation Leveraging variation in prevalence, severity and treatment response among different subpopulations of IgA to uncover subtype-specific targetsRead more

day: Pre-Conference Seminar Day

Panel Discussion | Evaluating the Evolving Treatment Landscape for IgA Nephropathy: What Happens Next as More & More Therapies Emerge? 2:45 pm

As more approvals emerge within the IgAN landscape, how will the evolving standard of care make showing efficacy on top of these other therapies harder? It may require multiple therapies with distinct MOAs to optimally treat the patient with IgAN; how can industry best help enhance further knowledge about the efficacy and safety of potential…Read more

day: Pre-Conference Seminar Day

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.